Salveo Capital

Salveo Capital is a private equity firm dedicated to supporting high-growth businesses within the legal cannabis industry. Established in 2016 and based in Northbrook, Illinois, the firm focuses on companies that provide ancillary products and services, including financial services, ag-tech, software, bio-pharma, and business services. Salveo Capital aims to build long-term sustainable companies that will reshape the image of legal cannabis and contribute to a vibrant market.

The firm's investment strategy emphasizes partnering with entrepreneurs who have the vision and drive to bring innovative ideas to life, offering both capital and strategic support. Salveo Capital invests in technologies, products, and services that address the unique requirements of the cannabis industry, fostering innovation and growth. The firm has a history of investing in early-stage businesses enabling the cannabis industry, particularly those ancillary to the production or processing of the plant and not subject to state regulations.

Salveo Capital's portfolio includes investments in companies like PathogenDx, Flow Kana, Headset, and others. Their approach has been highlighted in a 2018 Business Wire press release announcing an investment in PathogenDx. The firm is set to continue partnering closely with entrepreneurs, offering capital, strategic guidance, and operational support to scale innovative cannabis ventures as the industry evolves.